Home > Boards > US Listed > Biotechs > RedHill Biopharma Ltd. (RDHL)

Doesn't suck at all, and financials were as

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Spideyboy Member Profile
 
Followed By 8
Posts 663
Boards Moderated 0
Alias Born 04/07/08
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/18/2020 7:02:33 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 9:56:32 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/27/2020 4:28:04 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/27/2020 7:01:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/21/2020 7:15:44 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/2/2020 9:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/17/2019 8:01:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2019 8:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/20/2019 7:00:59 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/19/2019 7:01:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/15/2019 8:01:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/13/2019 7:00:57 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/12/2019 7:01:02 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/6/2019 2:35:27 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/4/2019 6:06:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/29/2019 8:01:26 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/28/2019 9:04:03 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/18/2019 6:02:07 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2019 8:01:29 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2019 9:01:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 6:31:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/26/2019 8:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/27/2019 7:01:19 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/21/2019 7:01:01 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/9/2019 6:00:55 AM
Spideyboy   Thursday, 11/21/19 03:52:19 AM
Re: Locke1 post# 1786
Post # of 1826 
Doesn't suck at all, and financials were as to be expected and gearing up nicely for Talicia launch.

Their R&D expenses have been dramatically reduced due to completing the Talicia Phase III, but marketing/sales and Admin expenses are up due to gearing for launch, which would be worrisome if this were not the case.

The sales of current marketed drugs on their list aren't going to wow anyone, and I don't think any of us are in this stock because of those.

They have probably about 55 million in the bank as of now and at current expenses will last them 5 quarters (4 quarters from Talicia planned launch) which should hopefully allow good traction to take hold on Talicia. Also will be interesting to see how the new Aemcolo performs for revenues.

Doesn't suck at all and indeed very believable.

Let's see what tomorrow's Talicia and Aemcolo marketing strategy call holds.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist